S Gershon

1.2k total citations
59 papers, 842 citations indexed

About

S Gershon is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, S Gershon has authored 59 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Psychiatry and Mental health, 10 papers in Cellular and Molecular Neuroscience and 9 papers in Molecular Biology. Recurrent topics in S Gershon's work include Bipolar Disorder and Treatment (11 papers), Schizophrenia research and treatment (9 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). S Gershon is often cited by papers focused on Bipolar Disorder and Treatment (11 papers), Schizophrenia research and treatment (9 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). S Gershon collaborates with scholars based in United States, Australia and Austria. S Gershon's co-authors include Baron Shopsin, Burton Angrist, Burt Angrist, Robert Pohl, Bromfield Hine, ‌Barry Reisberg, Steven H. Ferris, Andrew Lautin, M. Stanley and E. M. Trautner and has published in prestigious journals such as Nature, The Lancet and American Journal of Psychiatry.

In The Last Decade

S Gershon

58 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S Gershon United States	17	369	319	165	143	96	59	842
Bo Siwers Sweden	17	292 0.8×	228 0.7×	256 1.6×	192 1.3×	94 1.0×	23	865
Joseph C. Schoolar United States	16	253 0.7×	266 0.8×	112 0.7×	153 1.1×	43 0.4×	41	873
Jack E. Rosenblatt United States	12	309 0.8×	325 1.0×	69 0.4×	180 1.3×	62 0.6×	18	737
B. Fyrö Sweden	18	374 1.0×	325 1.0×	102 0.6×	144 1.0×	52 0.5×	35	908
P Deniker France	17	435 1.2×	222 0.7×	155 0.9×	145 1.0×	54 0.6×	113	980
Post Rm United States	14	381 1.0×	235 0.7×	85 0.5×	93 0.7×	108 1.1×	29	731
Goodwin Fk United States	18	413 1.1×	311 1.0×	244 1.5×	181 1.3×	36 0.4×	44	1.1k
Cal K. Cohn United States	13	335 0.9×	176 0.6×	344 2.1×	186 1.3×	59 0.6×	19	1.0k
Vivi‐Ann Ringberger Sweden	7	304 0.8×	333 1.0×	300 1.8×	118 0.8×	159 1.7×	7	943
V. Pedersen Denmark	14	272 0.7×	260 0.8×	139 0.8×	142 1.0×	52 0.5×	22	728

Countries citing papers authored by S Gershon

Since Specialization

Citations

This map shows the geographic impact of S Gershon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Gershon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Gershon more than expected).

Fields of papers citing papers by S Gershon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Gershon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Gershon. The network helps show where S Gershon may publish in the future.

Co-authorship network of co-authors of S Gershon

This figure shows the co-authorship network connecting the top 25 collaborators of S Gershon. A scholar is included among the top collaborators of S Gershon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Gershon. S Gershon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Angrist, Burt, John Rotrosen, & S Gershon. (2001). Commentary on: "Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia." Psychopharmacology (1980) 72:17-19. Psychopharmacology. 158(3). 219–221. 4 indexed citations

Soares, Jair C. & S Gershon. (2000). The psychopharmacologic specificity of the lithium ion: origins and trajectory.. PubMed. 61 Suppl 9. 16–22. 15 indexed citations

Gershon, S, et al.. (1999). Early North American research on lithium. Australian & New Zealand Journal of Psychiatry. 33(s1). S48–S53. 9 indexed citations

Balon, Richard, et al.. (1990). Monosodium glutamate and tranylcypromine administration in healthy subjects.. PubMed. 51(7). 303–6. 2 indexed citations

Pohl, Robert, et al.. (1987). Are tricyclic antidepressants effective for aphthous ulcers?. PubMed. 48(6). 256–256. 4 indexed citations

Pomara, Nunzio, Miriam Banay‐Schwartz, Robert I. Block, Michael Stanley, & S Gershon. (1983). Elevation of RBC glycine and choline levels in geriatric patients treated with lithium. American Journal of Psychiatry. 140(7). 911–913. 11 indexed citations

Lautin, Andrew, et al.. (1980). Sodium Valproate in Schizophrenia: Some Biochemical Correlates. The British Journal of Psychiatry. 137(3). 240–244. 41 indexed citations

Reisberg, ‌Barry, Steven H. Ferris, & S Gershon. (1980). Pharmacotherapy of senile dementia.. PubMed. 69. 233–64. 3 indexed citations

Lautin, Andrew, M. Stanley, Burton Angrist, & S Gershon. (1979). Extrapyramidal syndrome with sodium valproate.. BMJ. 2(6197). 1035.2–1036. 17 indexed citations

10.

Hine, Bromfield, et al.. (1977). Analgesic, heart rate, and temperature effects of delta8-THC during acute and chronic administration to conscious rats.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 15(1). 63–72. 22 indexed citations

11.

Gershon, S, Burton Angrist, & Baron Shopsin. (1975). Drugs, diagnosis, and disease.. PubMed. 54. 85–100. 9 indexed citations

12.

Angrist, Burt, et al.. (1974). The Antagonism of Amphetamine-Induced Symptomatology by a Neuroleptic. American Journal of Psychiatry. 131(7). 817–819. 92 indexed citations

13.

Shopsin, Baron, Ewan R. Pearson, S Gershon, & Patrick Collins. (1972). A controlled double-blind comparison between loxapine succinate and chlorpromazine in acute newly hospitalized schizophrenic patients.. PubMed. 14(11). 739–48. 17 indexed citations

14.

Angrist, Burt & S Gershon. (1971). A Pilot Study of Pathogenic Mechanisms in Amphetamine Psychosis Utilizing Differential Effects of D and L Amphetamine^*. Pharmacopsychiatry. 4(2). 64–75. 10 indexed citations

15.

Gershon, S. (1970). On the pharmacology of marihuana.. PubMed. 1(10). 9–18. 12 indexed citations

16.

Floyd, A, et al.. (1967). Clinical trial of an acridane derivative (SKF No. 14,336) in male schizophrenics.. PubMed. 9(1). 17–23. 1 indexed citations

17.

Ml, Brown, et al.. (1966). Effects of chronic chlorpromazine administration upon the blood pressure responses to autonomic drugs in conscious dogs.. PubMed. 162(2). 330–44. 7 indexed citations

18.

Gershon, S, et al.. (1963). Some aspects of the mode of action of imipramine.. PubMed. 4. 224–31. 16 indexed citations

19.

Gershon, S & E. M. Trautner. (1954). THE TREATMENT OF DEPRESSIVE PSYCHOSIS WITH SODIUM SUCCINATE. The Medical Journal of Australia. 2(8). 291–293. 4 indexed citations

20.

Trautner, E. M., et al.. (1954). TREATMENT OF SCHIZOPHRENIA BY COMBINED BARBITURATE‐SUCCINATE THERAPY. The Medical Journal of Australia. 2(5). 181–183. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact